| Serial Number | 98436739 |
| Word Mark | INFLAMOSTAT |
| Filing Date | Wednesday, March 6, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, December 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
| Goods and Services | Synthetic and collagen peptides for use in the fields of medical diagnostics and biotechnology, namely, for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; pharmaceutical preparations for use in the fields of medical diagnostics and biotechnology, namely, topical drugs for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides for pharmaceutical purposes for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides for the treatment of various conditions and diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides sold as ingredient in pharmaceutical preparations for the treatment immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; pharmaceutical preparations containing synthetic and collagen peptides for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; chemical preparations for sanitary use, namely, for coating medical devices, and for wound dressings; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; injectable pharmaceuticals for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; |
| Goods and Services | Cosmetics; ingredient complex composed of synthetic and collagen peptides sold as an integral component of cosmetic preparations; |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 6, 2024 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | 3Helix Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84108 |
| Event Date | Event Description |
| Wednesday, March 6, 2024 | NEW APPLICATION ENTERED |
| Thursday, July 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 19, 2024 | ASSIGNED TO EXAMINER |
| Saturday, September 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, September 21, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, September 21, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, December 9, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, December 9, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 9, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, December 9, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, December 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |